FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 117 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 6.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $55,805,000 | +112.5% | 1,481,405 | -4.0% | 0.02% | +100.0% |
| Q4 2020 | $26,263,000 | +253.1% | 1,543,780 | -2.5% | 0.01% | +200.0% |
| Q3 2020 | $7,438,000 | -27.0% | 1,582,570 | -5.3% | 0.00% | -25.0% |
| Q2 2020 | $10,194,000 | +149.0% | 1,670,815 | -7.3% | 0.00% | +100.0% |
| Q1 2020 | $4,094,000 | -47.5% | 1,803,218 | +6.1% | 0.00% | -33.3% |
| Q4 2019 | $7,799,000 | +16.6% | 1,699,355 | -1.5% | 0.00% | 0.0% |
| Q3 2019 | $6,690,000 | -36.3% | 1,726,052 | -0.9% | 0.00% | -25.0% |
| Q2 2019 | $10,505,000 | -52.7% | 1,742,106 | +5.0% | 0.00% | -55.6% |
| Q1 2019 | $22,228,000 | +61.0% | 1,658,706 | +11.8% | 0.01% | +50.0% |
| Q4 2018 | $13,803,000 | -29.8% | 1,484,178 | +5.0% | 0.01% | -14.3% |
| Q3 2018 | $19,671,000 | +4.6% | 1,413,177 | +18.8% | 0.01% | 0.0% |
| Q2 2018 | $18,808,000 | +5.1% | 1,189,654 | +14.2% | 0.01% | 0.0% |
| Q1 2018 | $17,897,000 | -16.2% | 1,041,750 | +6.9% | 0.01% | -22.2% |
| Q4 2017 | $21,357,000 | -40.1% | 974,276 | +11.8% | 0.01% | -43.8% |
| Q3 2017 | $35,651,000 | +33.1% | 871,497 | -2.0% | 0.02% | +33.3% |
| Q2 2017 | $26,787,000 | -20.6% | 889,576 | -4.7% | 0.01% | -25.0% |
| Q1 2017 | $33,743,000 | -19.9% | 933,410 | +11.0% | 0.02% | -23.8% |
| Q4 2016 | $42,147,000 | +7.4% | 841,072 | +12.5% | 0.02% | 0.0% |
| Q3 2016 | $39,255,000 | +101.3% | 747,861 | +58.6% | 0.02% | +90.9% |
| Q2 2016 | $19,498,000 | – | 471,536 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|